Automated description from the Alliance of Genome Resources (Release 3.1)
Predicted to have RNA polymerase II C-terminal domain binding activity; S-adenosyl-L-methionine binding activity; and mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity. Involved in mRNA methylation. Predicted to localize to intercellular bridge; microtubule cytoskeleton; and nucleoplasm. Orthologous to human PCIF1 (PDX1 C-terminal inhibiting factor 1).